Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in Cancer.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
entrez:
6
1
2022
pubmed:
7
1
2022
medline:
30
4
2022
Statut:
ppublish
Résumé
Despite advances in molecular therapeutics, few anticancer agents achieve durable responses. Rational combinations using two or more anticancer drugs have the potential to achieve a synergistic effect and overcome drug resistance, enhancing antitumor efficacy. A publicly accessible biomedical literature search engine dedicated to this domain will facilitate knowledge discovery and reduce manual search and review. We developed RetriLite, an information retrieval and extraction framework that leverages natural language processing and domain-specific knowledgebase to computationally identify highly relevant papers and extract key information. The modular architecture enables RetriLite to benefit from synergizing information retrieval and natural language processing techniques while remaining flexible to customization. We customized the application and created an informatics pipeline that strategically identifies papers that describe efficacy of using combination therapies in clinical or preclinical studies. In a small pilot study, RetriLite achieved an RetriLite is a framework that can be applied to establish domain-specific information retrieval and extraction systems. The extensive and high-quality metadata tags along with keyword highlighting facilitate information seekers to more effectively and efficiently discover knowledge in the combination therapy domain.
Identifiants
pubmed: 34990212
doi: 10.1200/CCI.21.00109
pmc: PMC9848576
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2100109Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000371
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
JCO Clin Cancer Inform. 2021 Jan;5:102-111
pubmed: 33439724
JCO Clin Cancer Inform. 2019 Jul;3:1-11
pubmed: 31265323
Oncotarget. 2017 Jun 6;8(23):38022-38043
pubmed: 28410237
Nucleic Acids Res. 2018 Jan 4;46(D1):D1121-D1127
pubmed: 29140520
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D54-8
pubmed: 15608257
Cancer Sci. 2011 Jul;102(7):1374-80
pubmed: 21443688
BMC Bioinformatics. 2009 Feb 05;10 Suppl 2:S6
pubmed: 19208194
J Clin Oncol. 2013 Sep 10;31(26):3219-25
pubmed: 23918952
Nature. 2019 Sep;573(7775):S100-S102
pubmed: 31554996
Cancers (Basel). 2018 Dec 04;10(12):
pubmed: 30518036
Nucleic Acids Res. 2014 Jan;42(Database issue):D1091-7
pubmed: 24203711
Nucleic Acids Res. 2018 Jan 4;46(D1):D1068-D1073
pubmed: 29156001
J Am Med Inform Assoc. 2016 Jul;23(4):758-65
pubmed: 27107438